A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Graybug Vision
- Study ID
- NCT03249740
- Phase
- PHASE1
- Status
- Completed
Conditions
- Neovascular Age-Related Macular Degeneration
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- GB-102 — DRUGIntravitreal injection of GB-102
- Aflibercept — DRUGIntravitreal injection of Aflibercept.
Study Details
The purpose of this study is to evaluate the safety and efficacy of single and repeated intravitreal injections of GB-102 in subjects with neovascular (wet) age-related macular degeneration.
Key Dates
- Start date
- Aug 29, 2017
- Status verified
- Dec 2019
- Primary completion
- Sep 13, 2018
- Completion
- Jan 16, 2019
Study Design
- Enrollment
- 32 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental: Phase 1 - GB-102Subjects will be assigned to 1 of 4 cohorts to receive a single intravitreal injection of up to 2.0 mg (50 μL) GB-102.
- Experimental: Experimental: Phase 2 - GB-102Low dose or high dose injected every 6 months
- Active Comparator: Active Comparator: Phase 2 - AfliberceptAflibercept 2 mg injected every 2 months
Primary Outcome Measure
Phase 1: Occurrence of ocular and nonocular adverse events (AEs) [ Time Frame: 8 months ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Retinal Consultants of Arizona | Gilbert | Arizona | 85296 | - |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | - |
| Midwest Eye Institute | Indianapolis | Indiana | 46290 | - |
| Ophthalmic Consultants of Long Island | Lynbrook | New York | 11563 | - |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | - |
| Texas Retina Associates | Arlington | Texas | 76012 | - |
| Retina Research Center, PLLC | Austin | Texas | 78705 | - |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | - |
Find similar trials in Gilbert, AZ
Related Studies
- Extension Study for the Port Delivery System With Ranibizumab (Portal)PHASE3 · Recruiting · Hoffmann-La Roche · Phoenix, Arizona
- Long-term Follow-Up Study of RGX-314 and Fellow Eye SubstudyPHASE2 · Enrolling By Invitation · AbbVie · Phoenix, Arizona
- A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)PHASE4 · Recruiting · Genentech, Inc. · Mesa, Arizona
- Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMDPHASE3 · Recruiting · Jaeb Center for Health Research · Glendale, California